US 12404313
GDNF fusion polypeptides and methods of use thereof
granted A61KA61K38/00A61P
Quick answer
US patent 12404313 (GDNF fusion polypeptides and methods of use thereof) held by Keros Therapeutics, Inc. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Keros Therapeutics, Inc.
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61P, A61P25/00, A61P3/00